How is X-linked chondrodysplasia punctata diagnosed?

Information about how this condition is diagnosed is currently limited for this condition.

Are there treatments for X-linked chondrodysplasia punctata?

Information about treatment options and management strategies is currently limited for this condition.

What complications can arise from X-linked chondrodysplasia punctata?

Currently, there is limited information about the specific complications that can arise from X-linked chondrodysplasia punctata. However, since it affects bone and cartilage development, individuals may face challenges related to skeletal growth. It's important to monitor any changes and consult with healthcare providers for personalized care.

How does X-linked chondrodysplasia punctata affect daily life?

Living with X-linked chondrodysplasia punctata may involve challenges related to mobility and physical activities due to skeletal changes. Families may need to adapt their daily routines and environments to support the individual's needs. Working with healthcare professionals can help create strategies for better management.

What is the prognosis for someone with X-linked chondrodysplasia punctata?

Information about the prognosis for individuals with X-linked chondrodysplasia punctata is currently limited. Since this condition affects bone and cartilage development, the outlook may vary from person to person. Regular check-ups with healthcare providers can help monitor health and provide support.

Are there any specialists that should be involved in the care of someone with X-linked chondrodysplasia punctata?

While specific recommendations for specialists are not provided, individuals with X-linked chondrodysplasia punctata may benefit from seeing orthopedic specialists. These doctors can help manage skeletal issues and provide guidance on physical activities. It's important to have a healthcare team that understands the condition for the best support.

Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

X-linked chondrodysplasia punctata (CPXD) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

X-linked chondrodysplasia punctata

MONDO:0010556

Also known as:CPXDchondrodysplasia punctata, X-linkedchondrodystrophia calcificans congenita

Overview

X-linked form of chondrodysplasia punctata.

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

No HPO annotations are available for this condition.

GeneReviews

Clinical Guidance

Affected Males The most consistent clinical features of X-linked chondrodysplasia punctata 1 (CDPX1) in affected males are chondrodysplasia punctata (CDP), brachytelephalangy, and nasomaxillary hypoplasia. Most affected males have minimal morbidity, and skeletal findings improve by adulthood; however, some have significant medical problems including airway stenosis and cervical spine instability. To date, approximately 50 individuals with a pathogenic variant in ARSL have been reported in the literature. The following description of the phenotypic features associated with this condition is based on the case series from and . Table 2. Chondrodysplasia Punctata 1, X-Linked: Frequency of Select Features

Diagnosis

Drawn from GeneReviews diagnostic guidelines, newborn screening panel status (RUSP), and ClinGen gene-disease validity classifications. Reflects current clinical evidence and consensus where available.

GeneReviews

Diagnostic Criteria

Suggestive Findings

X-linked chondrodysplasia punctata 1 (CDPX1) should be suspected in a male proband with the following clinical and radiographic findings.

Clinical findings

Brachytelephalangy (shortening of the distal phalanges)
Nasomaxillary hypoplasia

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for X-linked chondrodysplasia punctata. The disease remains an area of unmet medical need.

GeneReviews

Management Guidelines

Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with X-linked chondrodysplasia punctata 1 (CDPX1), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Chondrodysplasia Punctata 1, X-Linked

Prognosis

Based on GeneReviews surveillance recommendations, HPO phenotype frequency and severity annotations, and published prevalence estimates from Orphanet and OMIM.

GeneReviews

Surveillance Guidelines

Table 6. Recommended Surveillance for Individuals with Chondrodysplasia Punctata 1, X-Linked

System/Concern

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for X-linked chondrodysplasia punctata.

10 publications have been identified in PubMed for X-linked chondrodysplasia punctata. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (10%).

Research Type	Count	% of Total
Patient case studies	5	50%

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:06 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

FAQ

Frequently Asked Questions

Common questions about X-linked chondrodysplasia punctata

X-linked chondrodysplasia punctata is a rare skeletal disorder that affects the development of bones and cartilage. The term 'X-linked' indicates that the condition is associated with changes on the X chromosome, which can influence how the disorder appears in different people. This condition is one type among the various forms of chondrodysplasia punctata, a group of disorders that affect skeletal development leading to distinctive bone changes. The information available is limited to its definition, which emphasizes that it is a form of chondrodysplasia punctata linked to the X chromosome. While more detailed insights such as the full range of symptoms or clinical findings are not provided, this summary outlines the basic understanding of the condition as a disorder affecting bone and cartilage growth.

Information about symptoms is currently limited for this condition.

Based on its name, X-linked chondrodysplasia punctata is caused by changes linked to the X chromosome. However, detailed descriptions of the genetic mutations or risk factors involved are not provided in the current sources. Associated genes include ARSL, EBP.

← Back to All Diseases

Feature	Proportion of Persons w/Feature1	Comment
Chondrodysplasia punctata (CDP)	45/462	CDP typically not visible on radiographs after age 3 yrs
Nasomaxillary hypoplasia	42/42	—
Brachytelephalangy	33/35	—
Short stature (height 5th %ile)	12/16	Postnatal onset
Significant respiratory abnormalities	17/23	Frequent respiratory infections, asthma, central apnea, tachypnea, neonatal respiratory distress, mechanical ventilation, tracheotomy, chronic nasal obstruction, nasal stents
Mixed conductive sensorineural hearing loss	13/18	—
Significant cervical spine abnormalities	10/16	Dysplasia or hypoplasia of cervical vertebrae, C1–C2 anterior subluxation, kyphosis, cervical cord compression, spinal canal stenosis
Delayed cognitive development	5/6	1. From , . Note: These studies may have an ascertainment bias towards more severely affected children. A child with brachytelephalangy, nasomaxillary hypoplasia, and tracheobronchial calcifications did not have CDP at age 14 months . Nasomaxillary hypoplasia.

System/Concern	Evaluation	Comment
Respiratory	Assessment of upper lower airways by ENT pulmonologist	If stridor is present Obstructive sleep
apnea	Polysomnography	If sleep apnea is suspected Skeletal
instability	Flexion, neutral, extension lateral radiographs of the cervical spine	Cervical spine MRI if clinical evidence of cervical myelopathy or significant instability on radiographs; Special consideration when performing this study in flexion extension positions as spinal cord compression may only occur w/these movements (i.e.
Audiology	Hearing assessment	To assess for sensorineural conductive hearing loss
Developmental delay	Developmental assessment	Ophthalmologic
abnormalities	Ophthalmologic eval	To evaluate for cataracts, optic disc atrophy, small optic nerves
Cardiac anomalies	Echocardiogram	To evaluate for patent ductus arteriosus, ventricular septal defect, atrial septal defect, pulmonary artery stenosis
Genetic counseling	By genetics professionals2	To inform affected persons families re nature, MOI, implications of CDPX1 in order to facilitate medical personal decision making Family support resources

Kisho

X-linked chondrodysplasia punctata

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Differential Diagnosis

VKORC1

Clinical Guidance

Therapies Under Investigation

Clinical Trials

Recent Publications

X-linked chondrodysplasia punctata

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is X-linked chondrodysplasia punctata?

What are the symptoms of X-linked chondrodysplasia punctata?

What causes X-linked chondrodysplasia punctata?

How is X-linked chondrodysplasia punctata diagnosed?

Are there treatments for X-linked chondrodysplasia punctata?

What complications can arise from X-linked chondrodysplasia punctata?

How does X-linked chondrodysplasia punctata affect daily life?

What is the prognosis for someone with X-linked chondrodysplasia punctata?

Are there any specialists that should be involved in the care of someone with X-linked chondrodysplasia punctata?

Differential Diagnosis

VKORC1

Clinical Guidance

Therapies Under Investigation

Clinical Trials

Recent Publications